Recent advance in anti-osteoporotic therapy

Hao-Chang Hung, Ming Che Chuang, Horng-Yih Ou, Shu Hwa Hsiao, Ta Jen Wu

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Osteoporosis is becoming a serious public health issue in the world. The major complication of osteoporosis is fracture, especially vertebral and hip. These fractures lead to a high one-year mortality rate, and burden not only economically but also socially. To prevent and treat osteoporosis is important due to the symptoms happened only after a fracture. The current management of osteoporosis includes non-pharmacologic, such as exercise, calcium and vitamin D, and pharmacologic therapy, such as bisphosphonates, estrogen, SERM, calcitonin, strontium ranelate and iPTH. The effects of combination therapy, sequential therapy and developing medications on bone mineral density and fracture risk reduction will be clarified in the future.

Original languageEnglish
Pages (from-to)313-321
Number of pages9
JournalJournal of Internal Medicine of Taiwan
Volume18
Issue number6
Publication statusPublished - 2007 Dec 1

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Fingerprint Dive into the research topics of 'Recent advance in anti-osteoporotic therapy'. Together they form a unique fingerprint.

Cite this